Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study
International Journal of Clinical Oncology · 2026
DOI: 10.1007/s10147-026-03155-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Clinical Oncology, 2026. Verfasst von Kota Ishioka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-8550, Japan. kotaishioka@gm…. Hauptthemen laut MEDLINE: Germ-Line Mutation, Neoplasms. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Adolescents and young adults (AYA) aged 15 to 39 years with cancer have a higher prevalence of germline pathogenic variants than older patients. This study characterized the prevalence and distribution of germline pathogenic/likely pathogenic variants (GPVs) in Japanese AYA with advanced solid tumors using nationwide real-world paired tumor and normal sequencing data. METHODS: This retrospective study was conducted using a nationwide cancer genomics database in Japan. In total, 359 AYA with solid tumors who underwent comprehensive genomic profiling with a paired tumor and normal samples between June 2019 and December 2023 were included. The analyses were restricted to 39 genes for which germline findings, defined as variants detected in the matched normal sample within genes eligible for germline disclosure in Japan, are clinically reportable. RESULTS: Among 359 patients with advanced solid tumors, GPVs were identified in 32 patients, corresponding to a prevalence of 8.9%. Variants in the TP53 and BRCA2 genes were the most frequently identified. Notably, 13 of 32 cases were identified in an off-tumor context. In lung cancer, GPVs were identified in TP53 and BRCA2, indicating that GPVs in established cancer-predisposition genes can also be detected in tumor types not classically associated with these hereditary cancer genes. In univariable analysis, a family history of cancer and double cancer were associated with GPV positivity. CONCLUSIONS: This national paired tumor and normal sequencing study in Japanese AYA with cancer, identified GPVs including those detected in off-tumor contexts. Germline findings may warrant consideration beyond conventional approaches based on tumor type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Genetic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-8550, Japan. kotaishioka@gmail.com.
- Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan. kotaishioka@gmail.com.
- Department of Clinical Genetic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-8550, Japan.
- Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Medical Genetics and Genomics, Saitama Cancer Center, Saitama, Japan.
- Division of Data Science, Japanese Foundation for Cancer Research, Tokyo, Japan.
Zitieren
APA
Ishioka, K., Hayashi, N., Miyazaki, N., Dobashi, A., Habano, E., Kuga, A., Kaneko, K., Arakawa, H., Minoura, Y., Fukada, I., Yamazaki, M., Fukuda, N., Kataoka, A., Takano, T., Watanabe, M., Takahashi, S., Ueki, A., & Ono, M. (2026). Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03155-3
Vancouver
Ishioka K, Hayashi N, Miyazaki N, Dobashi A, Habano E, Kuga A, et al. Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study. International Journal of Clinical Oncology. 2026. doi:10.1007/s10147-026-03155-3
BibTeX
@article{Ishioka2026,
author = {Ishioka, Kota and Hayashi, Naomi and Miyazaki, Naoki and Dobashi, Akito and Habano, Eri and Kuga, Asami and Kaneko, Keika and Arakawa, Hiromi and Minoura, Yuko and Fukada, Ippei and Yamazaki, Masumi and Fukuda, Naoki and Kataoka, Akemi and Takano, Toshimi and Watanabe, Masayuki and Takahashi, Shunji and Ueki, Arisa and Ono, Makiko},
title = {Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study},
journal = {International Journal of Clinical Oncology},
year = {2026},
doi = {10.1007/s10147-026-03155-3}
}
EUVIMED